Blog

Home  /  Outputs   /  EUnetHTA Joint Action 2 (2012-15)   /  Second pilot rapid assessment on ‘canagliflozin for the treatment of type 2 diabetes mellitus’

Second pilot rapid assessment on ‘canagliflozin for the treatment of type 2 diabetes mellitus’

The purpose of the assessment is to evaluate canagliflozin ‘Invokana’ and its use as a treatment of type 2 diabetes mellitus.

Final version of the assessment was published in February 2014

Below is the documentation provided by the Joint Assessment authoring team:

Canagliflozin for the treatment of diabetes mellitus_Rapid REA_Final_Feb 2014